Lupin is one of the top Pharma companies with an excellent Balance Sheet, Sales Revenue growth and a very good future.
From long term investment point of view, this is an excellent company to have in your portfolio and current levels of 1250 are an excellent entry.
One can add more if it dips further as this stock itself promises to give 20% + returns within or much before an year..
Technically.. Weekly charts shows Fibonacci retracements to 50% and good chances of a bounce from here very soon...